These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 36741580)

  • 41. Metabolomics as a tool for discovery of biomarkers of autism spectrum disorder in the blood plasma of children.
    West PR; Amaral DG; Bais P; Smith AM; Egnash LA; Ross ME; Palmer JA; Fontaine BR; Conard KR; Corbett BA; Cezar GG; Donley EL; Burrier RE
    PLoS One; 2014; 9(11):e112445. PubMed ID: 25380056
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of Chromosome Microarray Analysis in a Large Cohort of Females with Autism Spectrum Disorders: A Single Center Italian Study.
    Calderoni S; Ricca I; Balboni G; Cagiano R; Cassandrini D; Doccini S; Cosenza A; Tolomeo D; Tancredi R; Santorelli FM; Muratori F
    J Pers Med; 2020 Oct; 10(4):. PubMed ID: 33050239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolomics of autism spectrum disorders: early insights regarding mammalian-microbial cometabolites.
    Mussap M; Noto A; Fanos V
    Expert Rev Mol Diagn; 2016 Aug; 16(8):869-81. PubMed ID: 27310602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estimation of the degree of autism spectrum disorder by the slow phase of optokinetic nystagmus in typical adults.
    Kanari K; Kikuchi-Ito M
    Heliyon; 2021 Aug; 7(8):e07751. PubMed ID: 34430740
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amino Acid Dysregulation Metabotypes: Potential Biomarkers for Diagnosis and Individualized Treatment for Subtypes of Autism Spectrum Disorder.
    Smith AM; King JJ; West PR; Ludwig MA; Donley ELR; Burrier RE; Amaral DG
    Biol Psychiatry; 2019 Feb; 85(4):345-354. PubMed ID: 30446206
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An Overview of Autism Spectrum Disorder, Heterogeneity and Treatment Options.
    Masi A; DeMayo MM; Glozier N; Guastella AJ
    Neurosci Bull; 2017 Apr; 33(2):183-193. PubMed ID: 28213805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Investigational drugs in early-stage clinical trials for autism spectrum disorder.
    Hong MP; Erickson CA
    Expert Opin Investig Drugs; 2019 Aug; 28(8):709-718. PubMed ID: 31352835
    [No Abstract]   [Full Text] [Related]  

  • 48. Abnormalities of EEG Functional Connectivity and Effective Connectivity in Children with Autism Spectrum Disorder.
    Geng X; Fan X; Zhong Y; Casanova MF; Sokhadze EM; Li X; Kang J
    Brain Sci; 2023 Jan; 13(1):. PubMed ID: 36672111
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Refining biomarker evaluation in ASD.
    McPartland JC
    Eur Neuropsychopharmacol; 2021 Jul; 48():34-36. PubMed ID: 33934921
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Attentional Connectivity-based Prediction of Autism Using Heterogeneous rs-fMRI Data from CC200 Atlas.
    Liu Y; Xu L; Li J; Yu J; Yu X
    Exp Neurobiol; 2020 Feb; 29(1):27-37. PubMed ID: 32122106
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical Assessment, Genetics, and Treatment Approaches in Autism Spectrum Disorder (ASD).
    Genovese A; Butler MG
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630718
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biomarkers in Neuropsychiatry: A Prospect for the Twenty-First Century?
    Pratt J; Hall J
    Curr Top Behav Neurosci; 2018; 40():3-10. PubMed ID: 29967998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dissecting the clinical heterogeneity of autism spectrum disorders through defined genotypes.
    Bruining H; de Sonneville L; Swaab H; de Jonge M; Kas M; van Engeland H; Vorstman J
    PLoS One; 2010 May; 5(5):e10887. PubMed ID: 20526357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Self-Construal Scale: A Potential Tool for Predicting Subjective Well-Being of Individuals With Autism Spectrum Disorder.
    Kaneko S; Kato TA; Makinodan M; Komori T; Ishida R; Kishimoto N; Takahashi M; Yasuda Y; Hashimoto R; Iwasaka H; Tanaka A; Uchida Y; Kanba S; Kishimoto T
    Autism Res; 2020 Jun; 13(6):947-958. PubMed ID: 31793248
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A genome-wide linkage study of autism spectrum disorder and the broad autism phenotype in extended pedigrees.
    Woodbury-Smith M; Paterson AD; O'Connor I; Zarrei M; Yuen RKC; Howe JL; Thompson A; Parlier M; Fernandez B; Piven J; Scherer SW; Vieland V; Szatmari P
    J Neurodev Disord; 2018 Jun; 10(1):20. PubMed ID: 29890955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Editorial Perspective: Longitudinal research in autism - introducing the concept of 'chronogeneity'.
    Georgiades S; Bishop SL; Frazier T
    J Child Psychol Psychiatry; 2017 May; 58(5):634-636. PubMed ID: 28414862
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeted Biomedical Treatment for Autism Spectrum Disorders.
    Pacheva I; Ivanov I
    Curr Pharm Des; 2019; 25(41):4430-4453. PubMed ID: 31801452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heterogeneity in Fragile X Syndrome Highlights the Need for Precision Medicine-Based Treatments.
    Verdura E; Pérez-Cano L; Sabido-Vera R; Guney E; Hyvelin JM; Durham L; Gomez-Mancilla B
    Front Psychiatry; 2021; 12():722378. PubMed ID: 34658958
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biomarkers in autism spectrum disorders: Current progress.
    Shen L; Liu X; Zhang H; Lin J; Feng C; Iqbal J
    Clin Chim Acta; 2020 Mar; 502():41-54. PubMed ID: 31857069
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leveraging Existing 16SrRNA Microbial Data to Define a Composite Biomarker for Autism Spectrum Disorder.
    Xu Y; Wang Y; Xu J; Song Y; Liu B; Xiong Z
    Microbiol Spectr; 2022 Aug; 10(4):e0033122. PubMed ID: 35762814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.